Pentokey Organy FY26 Results: Revenue up 153%, net profit falls 17%
- Revenue from operations jumped 153% YoY to ₹209.00 lakh in FY26
- Net profit fell 17% to ₹20.32 lakh due to higher stock purchases
- Trade receivables surged to ₹116.33 lakh from ₹29.35 lakh
- AGM scheduled for September 26, 2026, to approve results
*this image is generated using AI for illustrative purposes only.
Pentokey Organy has scheduled its 39th Annual General Meeting for September 26, 2026, to approve the financial results for FY26. The company reported total income of ₹249.80 lakh for the year ended March 31, 2026, compared to ₹129.05 lakh in the previous year.
Financial Performance
Revenue from operations surged 153% year-on-year to ₹209.00 lakh from ₹82.62 lakh in FY25. Despite the significant top-line growth, net profit declined 17% to ₹20.32 lakh against ₹24.55 lakh in the prior period. Other income stood at ₹40.79 lakh, down from ₹46.43 lakh last year.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue from Operations | ₹209.00 lakh | ₹82.62 lakh | +153.0% |
| Total Income | ₹249.80 lakh | ₹129.05 lakh | +93.5% |
| Net Profit | ₹20.32 lakh | ₹24.55 lakh | -17.2% |
What the Numbers Show
The divergence between revenue growth and profit contraction highlights margin pressure. While operational revenue more than doubled, total expenses rose sharply to ₹229.48 lakh from ₹104.50 lakh. Purchase of stock-in-trade increased by 84% to ₹192.96 lakh, outpacing revenue growth and compressing operating margins. Additionally, other income declined by ₹5.64 lakh, further weighing on the bottom line despite higher sales volumes.
Balance Sheet Position
Total assets decreased slightly to ₹943.84 lakh from ₹978.57 lakh. Trade receivables saw a substantial increase, rising to ₹116.33 lakh from ₹29.35 lakh, indicating slower collection cycles relative to sales growth. Cash and cash equivalents rose to ₹11.96 lakh from ₹7.97 lakh. The company maintained a strong liquidity position with no current liabilities reported in the balance sheet summary provided in the notes, although trade payables were listed as negative values in certain tables, suggesting potential data presentation anomalies or specific accounting treatments.
Corporate Actions
Shareholders will consider the re-appointment of Mr. Arun Goenka as a director, who retires by rotation. The board also seeks approval for the appointment of Ms. Kavita Kailash Bohra as an independent non-executive director for a five-year term commencing August 13, 2026. No dividend was recommended for the year as the company aims to conserve resources.
Historical Stock Returns for Pentokey Organy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.90% | -4.93% | -2.89% | -6.53% | -26.40% | 0.0% |
What specific operational strategies will Pentokey Organy implement to address the widening gap between revenue growth and rising stock-in-trade costs?
How does the significant increase in trade receivables impact the company's working capital efficiency, and what measures are being taken to accelerate collection cycles?
Will the appointment of Ms. Kavita Kailash Bohra as an independent director signal a shift in corporate governance or strategic direction for the board?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
